SPONSOR
Northside Hospital, Inc.
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Transplant-Related Hematologic MalignancyHematologic MalignancySevere Aplastic Anemia
NCT04237623 Phase 2
Recruiting
GM-CSF With Post-Transplant Cyclophosphamide
Transplant-Related Hematologic Malignancy
NCT05417971
Recruiting
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Hematologic Malignancy
NCT02828592 Phase 2
Recruiting
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Severe Aplastic Anemia